Analysis of isotonitazene by Blanckaert et al. demonstrated that isotonitazene is a strong opioid based upon its high potency and efficacy (4). "NPOs have increased μ-opioid receptor activation than morphine and fentanyl, that has previously been demonstrated by an in vitro review which pharmacologically evaluated 10 nitazenes working with 2 https://arthurrbksb.ssnblog.com/29334105/the-basic-principles-of-metonitazene-for-sale-in-australia